Values First Advisors »

Tg Therapeutics shares owned by Values First Advisors

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Values First Advisors from 13F filings

Historical chart of Values First Advisors investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Values First Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Values First Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $58k 2.5k 23.39

More positions owned by Values First Advisors

Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares U S Etf Tr Short Duration B (NEAR)
Emergent BioSolutions (EBS)
Ensign (ENSG)
Mid-America Apartment (MAA)
Synovus Finl Corp Com New (SNV)
Hackett (HCKT)
LeMaitre Vascular (LMAT)
National Retail Properties (NNN)
Cincinnati Financial Corporation (CINF)

View all positions for Values First Advisors

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Pictet Asset Management Holding SA
Geode Capital Management
Susquehanna International
Soleus Capital Management
Opaleye Management
Morgan Stanley
ClearBridge Advisors
Nuveen Asset Management
Deep Track Capital
Goodman & Company, Investment Counsel
Goldman Sachs Group
Northern Trust

View all funds holding Tg Therapeutics